Xcopri 100 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FYREU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,867
Award facts
- Contract value 100% obligated
- $2,866.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 18, 2025, for XCOPRI 100 mg tablets (30-count units) with a ceiling value of $2,866.68. This competitively awarded, firm fixed-price contract is scheduled for completion by September 19, 2025, with performance taking place at the vendor's Conshohocken facility. The award carries no set-aside designation, reflecting the company's ability to compete successfully in open procurement processes for federal pharmaceutical supplies.
This delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in the military medical supply chain, with consistent delivery orders for specialty pharmaceuticals and medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FYREU?
SPE2DB25FYREU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FYREU worth?
The government has obligated $2,867 on SPE2DB25FYREU.
Is contract SPE2DB25FYREU an order under another contract?
Yes. SPE2DB25FYREU is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYREU competed?
The extent of competition for SPE2DB25FYREU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award